Nexentis Soars 156% on AI Drug Discovery Plans, Shares Fall After the Bell
Nexentis Technologies Inc. shares soared more than 100% on Monday after a new AI drug-discovery update hit the tape. The small Nasdaq-listed name drew heavy trading interest for most of the session, though the stock pulled back some in after-hours trade.